Retail & Wholesale » Retail | Biostime International Holdings Ltd.

Biostime International Holdings Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,227
4,187
3,435
2,794
2,526
2,204
Total Accounts Receivable
156
174
1,008
683
1,008
1,090
Inventories
1,245
996
1,022
866
1,216
1,785
Other Current Assets
41
61
69
603
39
88
Total Current Assets
3,669
5,418
5,534
4,945
4,789
5,167
Net Property, Plant & Equipment
429
610
658
594
611
554
Total Investments and Advances
1,129
1,727
604
340
178
199
Long-Term Note Receivable
235
67
66
242
218
196
Intangible Assets
238
225
9,350
9,271
10,734
10,131
Other Assets
85
81
75
69
77
279
Total Assets
5,944
8,289
16,523
15,855
16,964
16,940
ST Debt & Current Portion LT Debt
970
6
5,667
2,211
967
Accounts Payable
454
362
729
585
759
Income Tax Payable
435
437
210
339
350
Other Current Liabilities
759
779
1,366
2,710
1,884
Total Current Liabilities
2,619
1,584
7,972
5,845
3,959
Long-Term Debt
-
3,097
3,254
5,366
6,591
Deferred Taxes
55
116
808
685
737
Other Liabilities
-
-
34
26
263
Total Liabilities
2,722
4,726
12,304
12,316
11,906
Common Equity (Total)
3,222
3,563
3,850
3,500
5,058
Total Shareholders' Equity
3,222
3,563
3,850
3,500
5,058
Total Equity
3,222
3,563
4,219
3,538
5,058
Liabilities & Shareholders' Equity
5,944
8,289
16,523
15,855
16,964
Accumulated Minority Interest
-
-
369
39
-

About Biostime International Holdings

View Profile
Address
29/F, Guangzhou Intl Finance Center
Guangzhou Guangdong 510623
China
Employees -
Website http://www.hh.global
Updated 07/08/2019
Health & Happiness (H&H) International Holdings Ltd. engages in the manufacture and sale of pediatric nutritional and baby care products. It operates through the following segments: Infant Formulas, Adult Nutrition and Care Products, and Other Pediatric Products. The Infant Formulas segment comprises the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.